文献速递外周动脉疾病

北欧式健走运动方案对外周动脉疾病患者获益的临床试验系统综述与Meta分析

Systematic Review and Meta-analysis of Clinical Trials Examining the Benefit of Exercise Programmes Using Nordic Walking in Patients With Peripheral Artery Disease.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-07-13

该系统综述与Meta分析共纳入5项临床试验、294例外周动脉疾病患者,比较北欧式健走与其他运动方案对最大步行距离的改善。汇总分析显示北欧式健走与标准步行方案对最大步行距离的改善相似(SMD=1.31,95%CI -1.28至3.91;p=.322),完全监督方案结果与主分析相似(SMD=-0.79,95%CI -2.81至1.24;p=.446),部分监督或居家方案则偏向北欧式健走(SMD=4.46,95%CI 3.39至5.53;p<.001),主要源于一项居家试验。作者认为需要更大规模的试验来验证该发现能否被重复。

要点

  • 北欧式健走与标准步行作为监督下运动方案对外周动脉疾病患者最大步行距离的改善相似(SMD=1.31,95%CI -1.28至3.91;p=.322)。
  • 完全监督方案亚组结果与主分析相似(SMD=-0.79,95%CI -2.81至1.24;p=.446)。
  • 部分监督或居家方案结果偏向北欧式健走(SMD=4.46,95%CI 3.39至5.53;p<.001),主要源于一项居家试验。

核心结论

  • 该系统综述提示北欧式健走作为外周动脉疾病的监督下运动方案,相较于标准步行未见获益。
  • 一项居家北欧式健走方案报告了有利结果,需要更大规模的试验来评估该发现能否被重复。

研究设计与样本

  • 系统检索比较外周动脉疾病患者北欧式健走与对照方案的临床试验,纳入标准为在入组和随访时均报告跑步机或走廊步行测试测得的最大步行距离。
  • 共纳入5项独立试验、294例患者;其中3项比较监督下北欧式健走与监督下标准步行,1项比较居家北欧式健走与相似的标准化步行方案,1项比较部分监督北欧式健走与最佳药物治疗。
  • 采用Cochrane协作组偏倚风险评估工具评价研究质量,并以逆方差加权Meta分析比较最大步行距离的改善。

主要发现

  • 全部数据的Meta分析提示北欧式健走与标准步行方案患者的最大步行距离改善相似(SMD=1.31,95%CI -1.28至3.91;p=.322)。
  • 完全监督方案的结果与主分析相似(SMD=-0.79,95%CI -2.81至1.24;p=.446)。
  • 部分监督或居家方案的结果偏向北欧式健走(SMD=4.46,95%CI 3.39至5.53;p<.001),主要源于一项居家试验的结果。

局限性

  • 原文结论指出需要更大规模的试验来评估居家北欧式健走方案的有利发现能否被重复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: An exercise programme is part of the initial management of peripheral artery disease (PAD). Nordic walking uses poles and a core-focused walking technique to reduce the load on the legs, which may have advantages as an exercise programme for PAD. This systematic review examined the benefit of a Nordic walking programme for treating PAD compared with other programmes. METHODS: A systematic approach was used to identify clinical trials comparing Nordic walking and control programmes in PAD patients. For inclusion, studies had to report maximum walking distance (MWD) measured with a treadmill test or corridor walking test both at entry and follow up. Study quality was appraised using the Cochrane collaboration tool for assessing risk of bias. An inverse variance weighted meta-analysis was performed to compare improvements in MWD. RESULTS: Five independent trials involving 294 patients were identified. In three trials, supervised Nordic walking programmes were compared with supervised standard walking. One trial compared a home based Nordic walking programme with a similar standard walking programme. One trial compared a partly supervised Nordic walking programme with best medical management. Meta-analysis of all data suggested that MWD improvements were similar for patients treated by Nordic and standard walking programmes (standardised mean difference, SMD = 1.31, 95% CI -1.28 to 3.91; p = .322). Findings for completely supervised programmes were similar to the primary analysis (SMD = -0.79, 95% CI -2.81 to 1.24; p = .446) while those from partially supervised or home based programmes favoured Nordic walking (SMD = 4.46, 95% CI 3.39, 5.53; p < .001), mainly due to results from one home based trial. CONCLUSIONS: This systematic review suggests no benefit of Nordic over standard walking as supervised exercise for PAD. Favourable results were reported for one home based Nordic walking programme. A larger trial is needed to assess whether this finding can be replicated or not.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Golledge J, Maarij K, Moxon JV, et al. Systematic Review and Meta-analysis of Clinical Trials Examining the Benefit of Exercise Programmes Using Nordic Walking in Patients With Peripheral Artery Disease. Eur J Vasc Endovasc Surg. 2018. PMID: 30017508. doi:10.1016/j.ejvs.2018.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。